A study, published in the Journal of Clinical Investigation titled “Single Dose Genome Editing Therapy Rescues Auditory and Vestibular Functions in Adult Mice with DFNA41 Deafness,” provides an example of a successful use of gene-editing technology to treat a mouse model of human genetic hearing loss.
This article was originally published on MedicalXpress.com